BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

In relation to Diabetes Mellitus more work will be required but data on at least 608 test subjects is a very good starting point to formulate a phase III or a phase III b trial.

In 2009, the diabetes treatment market generated worldwide sales of over $25 billion, with strong growth from the previous year. The incidence and prevalence of diabetes mellitus are on the rise worldwide, in line with lifestyle changes and ageing populations. In particular, the increasing prevalence of diabetes is closely linked with that of obesity, creating significant market opportunities in developed nations and some developing countries. The World Health Organization estimates the number of diabetics to exceed 350 million by 2030. Governments and other healthcare providers around the world are investing heavily in prevention and treatment of this serious - but controllable - disorder.

As our new report – World Diabetes Market Analysis 2010-2025 – shows, the diabetes market is one of the most important sectors in the pharmaceutical industry. All segments of the diabetes therapy market have been expanding, but which will grow fastest in years to come? What are the main therapeutic and commercial trends to watch?

Could the post menopausal women section end up migrating towards testosterone restoration (Libigel)?

Diabetes Market